The global market for Blood Compatible Nanocoating was valued at US$ 1124 million in the year 2024 and is projected to reach a revised size of US$ 1801 million by 2031, growing at a CAGR of 7.0% during the forecast period.

Blood Compatible Nanocoating Market

Blood Compatible Nanocoating refers to a class of functional surface materials engineered through nanostructure design and surface chemical modification to achieve superior hemocompatibility. These coatings are primarily applied to medical devices, implants, and extracorporeal circulation equipment that come into direct contact with blood. Their primary role is to minimize platelet adhesion, protein adsorption, and thrombus formation, thereby enhancing the biosafety and long-term stability of the material in blood-contacting environments. Typical applications include stents, artificial blood vessels, catheters, dialysis membranes, and heart valves. The technology utilizes plasma treatment, chemical vapor deposition, electrochemical coating, or self-assembled monolayers to form nanoscale interfaces incorporating hydrophilic polymers, bioinert molecules, and biomimetic layers. With the convergence of nanofabrication and biomaterials science, blood compatible nanocoatings are emerging as a key innovation in advanced medical device surface engineering.The average gross profit margin of this product is 40%.

The global blood compatible nanocoating market is undergoing rapid expansion, driven by the increasing demand for high-performance medical devices. The growing clinical adoption of cardiovascular intervention, dialysis therapy, and extracorporeal circulation systems is accelerating the need for anticoagulant and low-immunogenic materials. Advances in nanotechnology have enabled surface modifications with greater molecular precision and functional tunability, providing an innovative platform for next-generation hemocompatible coatings. Regulatory initiatives encouraging biosafety and sustainable materials are further promoting the commercialization of bioinert and biomimetic surface technologies. Moreover, the aging global population and rising incidence of chronic cardiovascular and renal diseases are catalyzing the modernization of medical devices and the widespread adoption of advanced coating technologies.

Despite its strong technological potential, the blood compatible nanocoating industry faces multiple challenges. The diverse surface properties of medical devices impose varying requirements for coating adhesion, wear resistance, and long-term biostability, complicating standardization. The potential toxicological risks of nanomaterials and uncertainties surrounding their in vivo degradation products have raised regulatory and ethical concerns. High R&D and manufacturing costs limit market entry for small and medium-sized enterprises, particularly regarding mass production and batch consistency. Furthermore, the industry still requires robust in-vitro and in-vivo validation frameworks and harmonized international standards to ensure long-term clinical reliability and safety.

Downstream demand is trending toward higher functionality and integration. Manufacturers in cardiovascular, neural, and dialysis sectors are transitioning from traditional polymer or metallic surfaces to nanocoating solutions with anticoagulant, antimicrobial, and self-healing properties. With the evolution of personalized medicine and miniaturized implants, intelligent blood-compatible coatings responsive to temperature or pH variations are entering the design pipeline. The growing focus of healthcare providers on extending device lifespan and minimizing postoperative complications is further accelerating the adoption of such coatings in disposable catheters, artificial valves, and blood pumps. In the future, the integration of digital manufacturing and surface engineering will enable more customized and standardized production of hemocompatible coatings.

The upstream segment of the blood compatible nanocoating industry encompasses functional polymers, bioinert molecules, nanoparticles, and coating substrate materials. Key raw materials include polyethylene glycol (PEG), polytetrafluoroethylene (PTFE), titanium oxide, zirconium oxide, silicon dioxide, hydroxyapatite, and biomimetic peptides. These components are chemically modified or structurally integrated to impart anti-protein adsorption and antithrombotic properties to coated surfaces. Advanced products adopt biodegradable nanocoating systems to ensure both implant safety and controlled degradation. Raw material purity, particle size distribution, and interfacial bonding strength are critical determinants of coating performance, while supply chain stability plays a decisive role in maintaining consistent production quality for medical-grade coatings.

This report aims to provide a comprehensive presentation of the global market for Blood Compatible Nanocoating, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Compatible Nanocoating.

The Blood Compatible Nanocoating market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Blood Compatible Nanocoating market comprehensively. Regional market sizes, concerning products by Type, by Application, by Functional Property and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Blood Compatible Nanocoating companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Blood Compatible Nanocoating Market Report

Report Metric	Details
Report Name	Blood Compatible Nanocoating Market
Accounted market size in year	US$ 1124 million
Forecasted market size in 2031	US$ 1801 million
CAGR	7.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Inorganic Nanocoatings Polymeric Nanocoatings Hybrid or Composite Nanocoatings
Segment by Functional Property	Antithrombogenic Anti-Fouling Antimicrobial
Segment by Application Area	Cardiovascular Devices Renal & Dialysis Devices Neurovascular Implants Orthopedic Implants Catheters & Guidewires Surgical/Extracorporeal Devices
Segment by Application	Medical Device Manufacturers R&D and Material Companies Hospitals & Research Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Surmodics, Hemoteq AG (Freudenberg), Biocoat, Covalon Technologies, Nanova Biomaterials, DSM Biomedical, NANOCOAT Medical, Harland Medical Systems, Daikin Industries, Applied Medical Coatings
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, by Functional Property etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Blood Compatible Nanocoating company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Blood Compatible Nanocoating Market growing?

Ans: The Blood Compatible Nanocoating Market witnessing a CAGR of 7.0% during the forecast period 2025-2031.

What is the Blood Compatible Nanocoating Market size in 2031?

Ans: The Blood Compatible Nanocoating Market size in 2031 will be US$ 1801 million.

Who are the main players in the Blood Compatible Nanocoating Market report?

Ans: The main players in the Blood Compatible Nanocoating Market are Surmodics, Hemoteq AG (Freudenberg), Biocoat, Covalon Technologies, Nanova Biomaterials, DSM Biomedical, NANOCOAT Medical, Harland Medical Systems, Daikin Industries, Applied Medical Coatings

What are the Application segmentation covered in the Blood Compatible Nanocoating Market report?

Ans: The Applications covered in the Blood Compatible Nanocoating Market report are Medical Device Manufacturers, R&D and Material Companies, Hospitals & Research Institutes

What are the Type segmentation covered in the Blood Compatible Nanocoating Market report?

Ans: The Types covered in the Blood Compatible Nanocoating Market report are Inorganic Nanocoatings, Polymeric Nanocoatings, Hybrid or Composite Nanocoatings

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Blood Compatible Nanocoating Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Inorganic Nanocoatings

1.2.3 Polymeric Nanocoatings

1.2.4 Hybrid or Composite Nanocoatings

1.3 Market by Functional Property

1.3.1 Global Blood Compatible Nanocoating Market Size Growth Rate by Functional Property: 2020 VS 2024 VS 2031

1.3.2 Antithrombogenic

1.3.3 Anti-Fouling

1.3.4 Antimicrobial

1.4 Market by Application Area

1.4.1 Global Blood Compatible Nanocoating Market Size Growth Rate by Application Area: 2020 VS 2024 VS 2031

1.4.2 Cardiovascular Devices

1.4.3 Renal & Dialysis Devices

1.4.4 Neurovascular Implants

1.4.5 Orthopedic Implants

1.4.6 Catheters & Guidewires

1.4.7 Surgical/Extracorporeal Devices

1.5 Market by Application

1.5.1 Global Blood Compatible Nanocoating Market Growth by Application: 2020 VS 2024 VS 2031

1.5.2 Medical Device Manufacturers

1.5.3 R&D and Material Companies

1.5.4 Hospitals & Research Institutes

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Blood Compatible Nanocoating Market Perspective (2020-2031)

2.2 Global Blood Compatible Nanocoating Growth Trends by Region

2.2.1 Global Blood Compatible Nanocoating Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Blood Compatible Nanocoating Historic Market Size by Region (2020-2025)

2.2.3 Blood Compatible Nanocoating Forecasted Market Size by Region (2026-2031)

2.3 Blood Compatible Nanocoating Market Dynamics

2.3.1 Blood Compatible Nanocoating Industry Trends

2.3.2 Blood Compatible Nanocoating Market Drivers

2.3.3 Blood Compatible Nanocoating Market Challenges

2.3.4 Blood Compatible Nanocoating Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Blood Compatible Nanocoating Players by Revenue

3.1.1 Global Top Blood Compatible Nanocoating Players by Revenue (2020-2025)

3.1.2 Global Blood Compatible Nanocoating Revenue Market Share by Players (2020-2025)

3.2 Global Top Blood Compatible Nanocoating Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Blood Compatible Nanocoating Revenue

3.4 Global Blood Compatible Nanocoating Market Concentration Ratio

3.4.1 Global Blood Compatible Nanocoating Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Blood Compatible Nanocoating Revenue in 2024

3.5 Global Key Players of Blood Compatible Nanocoating Head office and Area Served

3.6 Global Key Players of Blood Compatible Nanocoating, Product and Application

3.7 Global Key Players of Blood Compatible Nanocoating, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Blood Compatible Nanocoating Breakdown Data by Type

4.1 Global Blood Compatible Nanocoating Historic Market Size by Type (2020-2025)

4.2 Global Blood Compatible Nanocoating Forecasted Market Size by Type (2026-2031)

5 Blood Compatible Nanocoating Breakdown Data by Application

5.1 Global Blood Compatible Nanocoating Historic Market Size by Application (2020-2025)

5.2 Global Blood Compatible Nanocoating Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Blood Compatible Nanocoating Market Size (2020-2031)

6.2 North America Blood Compatible Nanocoating Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Blood Compatible Nanocoating Market Size by Country (2020-2025)

6.4 North America Blood Compatible Nanocoating Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Blood Compatible Nanocoating Market Size (2020-2031)

7.2 Europe Blood Compatible Nanocoating Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Blood Compatible Nanocoating Market Size by Country (2020-2025)

7.4 Europe Blood Compatible Nanocoating Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Blood Compatible Nanocoating Market Size (2020-2031)

8.2 Asia-Pacific Blood Compatible Nanocoating Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Blood Compatible Nanocoating Market Size by Region (2020-2025)

8.4 Asia-Pacific Blood Compatible Nanocoating Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Blood Compatible Nanocoating Market Size (2020-2031)

9.2 Latin America Blood Compatible Nanocoating Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Blood Compatible Nanocoating Market Size by Country (2020-2025)

9.4 Latin America Blood Compatible Nanocoating Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Blood Compatible Nanocoating Market Size (2020-2031)

10.2 Middle East & Africa Blood Compatible Nanocoating Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Blood Compatible Nanocoating Market Size by Country (2020-2025)

10.4 Middle East & Africa Blood Compatible Nanocoating Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Surmodics

11.1.1 Surmodics Company Details

11.1.2 Surmodics Business Overview

11.1.3 Surmodics Blood Compatible Nanocoating Introduction

11.1.4 Surmodics Revenue in Blood Compatible Nanocoating Business (2020-2025)

11.1.5 Surmodics Recent Development

11.2 Hemoteq AG (Freudenberg)

11.2.1 Hemoteq AG (Freudenberg) Company Details

11.2.2 Hemoteq AG (Freudenberg) Business Overview

11.2.3 Hemoteq AG (Freudenberg) Blood Compatible Nanocoating Introduction

11.2.4 Hemoteq AG (Freudenberg) Revenue in Blood Compatible Nanocoating Business (2020-2025)

11.2.5 Hemoteq AG (Freudenberg) Recent Development

11.3 Biocoat

11.3.1 Biocoat Company Details

11.3.2 Biocoat Business Overview

11.3.3 Biocoat Blood Compatible Nanocoating Introduction

11.3.4 Biocoat Revenue in Blood Compatible Nanocoating Business (2020-2025)

11.3.5 Biocoat Recent Development

11.4 Covalon Technologies

11.4.1 Covalon Technologies Company Details

11.4.2 Covalon Technologies Business Overview

11.4.3 Covalon Technologies Blood Compatible Nanocoating Introduction

11.4.4 Covalon Technologies Revenue in Blood Compatible Nanocoating Business (2020-2025)

11.4.5 Covalon Technologies Recent Development

11.5 Nanova Biomaterials

11.5.1 Nanova Biomaterials Company Details

11.5.2 Nanova Biomaterials Business Overview

11.5.3 Nanova Biomaterials Blood Compatible Nanocoating Introduction

11.5.4 Nanova Biomaterials Revenue in Blood Compatible Nanocoating Business (2020-2025)

11.5.5 Nanova Biomaterials Recent Development

11.6 DSM Biomedical

11.6.1 DSM Biomedical Company Details

11.6.2 DSM Biomedical Business Overview

11.6.3 DSM Biomedical Blood Compatible Nanocoating Introduction

11.6.4 DSM Biomedical Revenue in Blood Compatible Nanocoating Business (2020-2025)

11.6.5 DSM Biomedical Recent Development

11.7 NANOCOAT Medical

11.7.1 NANOCOAT Medical Company Details

11.7.2 NANOCOAT Medical Business Overview

11.7.3 NANOCOAT Medical Blood Compatible Nanocoating Introduction

11.7.4 NANOCOAT Medical Revenue in Blood Compatible Nanocoating Business (2020-2025)

11.7.5 NANOCOAT Medical Recent Development

11.8 Harland Medical Systems

11.8.1 Harland Medical Systems Company Details

11.8.2 Harland Medical Systems Business Overview

11.8.3 Harland Medical Systems Blood Compatible Nanocoating Introduction

11.8.4 Harland Medical Systems Revenue in Blood Compatible Nanocoating Business (2020-2025)

11.8.5 Harland Medical Systems Recent Development

11.9 Daikin Industries

11.9.1 Daikin Industries Company Details

11.9.2 Daikin Industries Business Overview

11.9.3 Daikin Industries Blood Compatible Nanocoating Introduction

11.9.4 Daikin Industries Revenue in Blood Compatible Nanocoating Business (2020-2025)

11.9.5 Daikin Industries Recent Development

11.10 Applied Medical Coatings

11.10.1 Applied Medical Coatings Company Details

11.10.2 Applied Medical Coatings Business Overview

11.10.3 Applied Medical Coatings Blood Compatible Nanocoating Introduction

11.10.4 Applied Medical Coatings Revenue in Blood Compatible Nanocoating Business (2020-2025)

11.10.5 Applied Medical Coatings Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Harland Medical Systems

Daikin Industries

Applied Medical Coatings

Hemoteq AG (Freudenberg)

NANOCOAT Medical

List of Tables

Table 1. Global Blood Compatible Nanocoating Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Inorganic Nanocoatings

Table 3. Key Players of Polymeric Nanocoatings

Table 4. Key Players of Hybrid or Composite Nanocoatings

Table 5. Global Blood Compatible Nanocoating Market Size Growth Rate by Functional Property (US$ Million): 2020 VS 2024 VS 2031

Table 6. Key Players of Antithrombogenic

Table 7. Key Players of Anti-Fouling

Table 8. Key Players of Antimicrobial

Table 9. Global Blood Compatible Nanocoating Market Size Growth Rate by Application Area (US$ Million): 2020 VS 2024 VS 2031

Table 10. Key Players of Cardiovascular Devices

Table 11. Key Players of Renal & Dialysis Devices

Table 12. Key Players of Neurovascular Implants

Table 13. Key Players of Orthopedic Implants

Table 14. Key Players of Catheters & Guidewires

Table 15. Key Players of Surgical/Extracorporeal Devices

Table 16. Global Blood Compatible Nanocoating Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Blood Compatible Nanocoating Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 18. Global Blood Compatible Nanocoating Market Size by Region (2020-2025) & (US$ Million)

Table 19. Global Blood Compatible Nanocoating Market Share by Region (2020-2025)

Table 20. Global Blood Compatible Nanocoating Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 21. Global Blood Compatible Nanocoating Market Share by Region (2026-2031)

Table 22. Blood Compatible Nanocoating Market Trends

Table 23. Blood Compatible Nanocoating Market Drivers

Table 24. Blood Compatible Nanocoating Market Challenges

Table 25. Blood Compatible Nanocoating Market Restraints

Table 26. Global Blood Compatible Nanocoating Revenue by Players (2020-2025) & (US$ Million)

Table 27. Global Blood Compatible Nanocoating Market Share by Players (2020-2025)

Table 28. Global Top Blood Compatible Nanocoating Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Compatible Nanocoating as of 2024)

Table 29. Ranking of Global Top Blood Compatible Nanocoating Companies by Revenue (US$ Million) in 2024

Table 30. Global 5 Largest Players Market Share by Blood Compatible Nanocoating Revenue (CR5 and HHI) & (2020-2025)

Table 31. Global Key Players of Blood Compatible Nanocoating, Headquarters and Area Served

Table 32. Global Key Players of Blood Compatible Nanocoating, Product and Application

Table 33. Global Key Players of Blood Compatible Nanocoating, Date of Enter into This Industry

Table 34. Mergers & Acquisitions, Expansion Plans

Table 35. Global Blood Compatible Nanocoating Market Size by Type (2020-2025) & (US$ Million)

Table 36. Global Blood Compatible Nanocoating Revenue Market Share by Type (2020-2025)

Table 37. Global Blood Compatible Nanocoating Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 38. Global Blood Compatible Nanocoating Revenue Market Share by Type (2026-2031)

Table 39. Global Blood Compatible Nanocoating Market Size by Application (2020-2025) & (US$ Million)

Table 40. Global Blood Compatible Nanocoating Revenue Market Share by Application (2020-2025)

Table 41. Global Blood Compatible Nanocoating Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 42. Global Blood Compatible Nanocoating Revenue Market Share by Application (2026-2031)

Table 43. North America Blood Compatible Nanocoating Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. North America Blood Compatible Nanocoating Market Size by Country (2020-2025) & (US$ Million)

Table 45. North America Blood Compatible Nanocoating Market Size by Country (2026-2031) & (US$ Million)

Table 46. Europe Blood Compatible Nanocoating Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Europe Blood Compatible Nanocoating Market Size by Country (2020-2025) & (US$ Million)

Table 48. Europe Blood Compatible Nanocoating Market Size by Country (2026-2031) & (US$ Million)

Table 49. Asia-Pacific Blood Compatible Nanocoating Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 50. Asia-Pacific Blood Compatible Nanocoating Market Size by Region (2020-2025) & (US$ Million)

Table 51. Asia-Pacific Blood Compatible Nanocoating Market Size by Region (2026-2031) & (US$ Million)

Table 52. Latin America Blood Compatible Nanocoating Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 53. Latin America Blood Compatible Nanocoating Market Size by Country (2020-2025) & (US$ Million)

Table 54. Latin America Blood Compatible Nanocoating Market Size by Country (2026-2031) & (US$ Million)

Table 55. Middle East & Africa Blood Compatible Nanocoating Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 56. Middle East & Africa Blood Compatible Nanocoating Market Size by Country (2020-2025) & (US$ Million)

Table 57. Middle East & Africa Blood Compatible Nanocoating Market Size by Country (2026-2031) & (US$ Million)

Table 58. Surmodics Company Details

Table 59. Surmodics Business Overview

Table 60. Surmodics Blood Compatible Nanocoating Product

Table 61. Surmodics Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)

Table 62. Surmodics Recent Development

Table 63. Hemoteq AG (Freudenberg) Company Details

Table 64. Hemoteq AG (Freudenberg) Business Overview

Table 65. Hemoteq AG (Freudenberg) Blood Compatible Nanocoating Product

Table 66. Hemoteq AG (Freudenberg) Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)

Table 67. Hemoteq AG (Freudenberg) Recent Development

Table 68. Biocoat Company Details

Table 69. Biocoat Business Overview

Table 70. Biocoat Blood Compatible Nanocoating Product

Table 71. Biocoat Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)

Table 72. Biocoat Recent Development

Table 73. Covalon Technologies Company Details

Table 74. Covalon Technologies Business Overview

Table 75. Covalon Technologies Blood Compatible Nanocoating Product

Table 76. Covalon Technologies Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)

Table 77. Covalon Technologies Recent Development

Table 78. Nanova Biomaterials Company Details

Table 79. Nanova Biomaterials Business Overview

Table 80. Nanova Biomaterials Blood Compatible Nanocoating Product

Table 81. Nanova Biomaterials Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)

Table 82. Nanova Biomaterials Recent Development

Table 83. DSM Biomedical Company Details

Table 84. DSM Biomedical Business Overview

Table 85. DSM Biomedical Blood Compatible Nanocoating Product

Table 86. DSM Biomedical Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)

Table 87. DSM Biomedical Recent Development

Table 88. NANOCOAT Medical Company Details

Table 89. NANOCOAT Medical Business Overview

Table 90. NANOCOAT Medical Blood Compatible Nanocoating Product

Table 91. NANOCOAT Medical Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)

Table 92. NANOCOAT Medical Recent Development

Table 93. Harland Medical Systems Company Details

Table 94. Harland Medical Systems Business Overview

Table 95. Harland Medical Systems Blood Compatible Nanocoating Product

Table 96. Harland Medical Systems Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)

Table 97. Harland Medical Systems Recent Development

Table 98. Daikin Industries Company Details

Table 99. Daikin Industries Business Overview

Table 100. Daikin Industries Blood Compatible Nanocoating Product

Table 101. Daikin Industries Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)

Table 102. Daikin Industries Recent Development

Table 103. Applied Medical Coatings Company Details

Table 104. Applied Medical Coatings Business Overview

Table 105. Applied Medical Coatings Blood Compatible Nanocoating Product

Table 106. Applied Medical Coatings Revenue in Blood Compatible Nanocoating Business (2020-2025) & (US$ Million)

Table 107. Applied Medical Coatings Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Blood Compatible Nanocoating Picture

Figure 2. Global Blood Compatible Nanocoating Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Blood Compatible Nanocoating Market Share by Type: 2024 VS 2031

Figure 4. Inorganic Nanocoatings Features

Figure 5. Polymeric Nanocoatings Features

Figure 6. Hybrid or Composite Nanocoatings Features

Figure 7. Global Blood Compatible Nanocoating Market Size Comparison by Functional Property (2020-2031) & (US$ Million)

Figure 8. Antithrombogenic Features

Figure 9. Anti-Fouling Features

Figure 10. Antimicrobial Features

Figure 11. Global Blood Compatible Nanocoating Market Size Comparison by Application Area (2020-2031) & (US$ Million)

Figure 12. Cardiovascular Devices Features

Figure 13. Renal & Dialysis Devices Features

Figure 14. Neurovascular Implants Features

Figure 15. Orthopedic Implants Features

Figure 16. Catheters & Guidewires Features

Figure 17. Surgical/Extracorporeal Devices Features

Figure 18. Global Blood Compatible Nanocoating Market Size by Application (2020-2031) & (US$ Million)

Figure 19. Global Blood Compatible Nanocoating Market Share by Application: 2024 VS 2031

Figure 20. Medical Device Manufacturers Case Studies

Figure 21. R&D and Material Companies Case Studies

Figure 22. Hospitals & Research Institutes Case Studies

Figure 23. Blood Compatible Nanocoating Report Years Considered

Figure 24. Global Blood Compatible Nanocoating Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 25. Global Blood Compatible Nanocoating Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 26. Global Blood Compatible Nanocoating Market Share by Region: 2024 VS 2031

Figure 27. Global Blood Compatible Nanocoating Market Share by Players in 2024

Figure 28. Global Blood Compatible Nanocoating Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 29. The Top 10 and 5 Players Market Share by Blood Compatible Nanocoating Revenue in 2024

Figure 30. North America Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. North America Blood Compatible Nanocoating Market Share by Country (2020-2031)

Figure 32. United States Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Canada Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Europe Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Europe Blood Compatible Nanocoating Market Share by Country (2020-2031)

Figure 36. Germany Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. France Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. U.K. Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Italy Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Russia Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Ireland Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Asia-Pacific Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Asia-Pacific Blood Compatible Nanocoating Market Share by Region (2020-2031)

Figure 44. China Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Japan Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. South Korea Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Southeast Asia Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. India Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Australia & New Zealand Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Latin America Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Latin America Blood Compatible Nanocoating Market Share by Country (2020-2031)

Figure 52. Mexico Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Brazil Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. Middle East & Africa Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. Middle East & Africa Blood Compatible Nanocoating Market Share by Country (2020-2031)

Figure 56. Israel Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 57. Saudi Arabia Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 58. UAE Blood Compatible Nanocoating Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 59. Surmodics Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)

Figure 60. Hemoteq AG (Freudenberg) Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)

Figure 61. Biocoat Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)

Figure 62. Covalon Technologies Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)

Figure 63. Nanova Biomaterials Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)

Figure 64. DSM Biomedical Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)

Figure 65. NANOCOAT Medical Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)

Figure 66. Harland Medical Systems Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)

Figure 67. Daikin Industries Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)

Figure 68. Applied Medical Coatings Revenue Growth Rate in Blood Compatible Nanocoating Business (2020-2025)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15J20209

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Hydrocolloid Waterproof Adhesive Bandages Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23Z19779

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adjustable Rollator Walker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36Q20015

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Multi-Functional Point Of Care Testin Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19G20218

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions